Sanofi-Synthelabo merger driven by pharmaceutical interests
This article was originally published in Clinica
Executive Summary
The French multinationals Sanofi and Synthelabo are to merge, creating a company with a combined 1998 turnover of Fr34.7 billion ($5.9 billion) and a market capitalisation of around $42 billion. In the medtech sector, Sanofi and Synthelabo compete in the diagnostics and medical devices markets with combined 1997 revenues of Fr2.3 billion.